Drug intelligence / Profile preview

Aminocaff Capsule

Development stage
Unknown
Lead developer
Ginwa Enterprise Group
Modality
Small Molecules
Administration
Oral
01

Overview

Aminocaff Capsule is an over-the-counter (OTC) combination medication developed by Jinhua Enterprise (Ginwa) for the symptomatic relief of the common cold and influenza. It contains paracetamol (acetaminophen), an analgesic and antipyretic that reduces fever and pain by inhibiting prostaglandin synthesis in the central nervous system; caffeine, a methylxanthine stimulant that may enhance the analgesic effect of paracetamol and counteract the sedative effects of antihistamines; and chlorpheniramine maleate, a first-generation H1-receptor antagonist that alleviates allergic symptoms such as rhinorrhea, sneezing, and watery eyes. This formulation is widely used in China for treating symptoms including headache, fever, joint pain, and nasal congestion associated with viral respiratory infections.

Brand names
Aminocaff Capsule氨咖黄敏胶囊
Other names
Compound Paracetamol and Chlorpheniramine Maleate Capsules
02

Targets

ADORA1 (Adenosine receptor A1 subtype)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)ADORA2A (Adenosine A₂A Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Aminocaff Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aminocaff Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call